An 85-year-old woman who has been on gabapentin for several years stopped it for three days and now has marked fatigue without other symptoms; how should she be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Gabapentin Withdrawal in an 85-Year-Old Woman

Immediately restart gabapentin at her previous maintenance dose, as this patient is experiencing gabapentin withdrawal syndrome after abrupt cessation of long-term therapy, and symptoms should resolve within 8-24 hours of reinitiation. 1, 2

Immediate Management

  • Restart gabapentin immediately at the patient's previous chronic dose, as withdrawal symptoms typically resolve within hours to 1-2 days after reinitiation 3, 4, 5
  • Fatigue is a recognized withdrawal symptom from gabapentin, along with confusion, agitation, anxiety, restlessness, and autonomic symptoms 3, 4, 5
  • The FDA label explicitly states that gabapentin should be discontinued gradually over a minimum of 1 week, not abruptly 2

Why This Occurred

  • Long-term gabapentin use (several years) creates physiological dependence, even at therapeutic doses, with approximately 50% of patients on chronic gabapentin therapy developing dependence 1
  • Withdrawal symptoms can occur after as little as 3 weeks of use, but are more common and severe with prolonged therapy 4, 6
  • Symptoms typically begin 12 hours to 7 days after discontinuation, with this patient presenting at 3 days 6
  • Elderly patients are at particular risk for withdrawal symptoms and may require longer tapers 5

Critical Assessment Points

Before restarting, briefly evaluate for:

  • Renal function status - gabapentin is renally excreted and elderly patients often have decreased creatinine clearance requiring dose adjustment 2
  • Concurrent opioid or benzodiazepine use - these combinations increase respiratory depression risk 1
  • Other causes of fatigue - though withdrawal is most likely, rule out acute medical illness, electrolyte abnormalities, or infection with basic vital signs and clinical assessment 3

Dosing Considerations for Elderly Patients

  • If renal function is impaired (common in 85-year-olds), adjust the restarted dose based on creatinine clearance 2
  • For CrCl 30-59 mL/min: maximum 1400 mg/day in divided doses 2
  • For CrCl 15-29 mL/min: maximum 700 mg/day as single daily dose 2
  • Do not use the reduced dose initially if withdrawal is severe - restart at previous dose then adjust downward gradually if needed 2

Future Discontinuation Strategy (If Desired)

Should discontinuation be reconsidered later:

  • Taper over weeks to months, not days - the FDA minimum of 1 week is insufficient for long-term users, especially elderly patients 2, 5
  • A benzodiazepine-like taper schedule is recommended: reduce by 10-25% every 1-2 weeks 5, 7
  • For patients on gabapentin for years, consider tapers lasting 2-3 months or longer 5
  • Monitor closely for withdrawal symptoms including anxiety, insomnia, nausea, pain, sweating, confusion, and in severe cases, seizures 7, 6

Common Pitfall to Avoid

Do not mistake gabapentin withdrawal for other conditions (delirium, infection, benzodiazepine withdrawal) and treat symptomatically with sedatives - this approach fails, as demonstrated in case reports where benzodiazepines were ineffective for gabapentin withdrawal 3, 4. The definitive treatment is gabapentin reinitiation, which produces rapid symptom resolution 3, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Withdrawal symptoms after gabapentin discontinuation.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010

Research

Akathisia induced by gabapentin withdrawal.

The Annals of pharmacotherapy, 2011

Research

Gabapentin: Abuse, Dependence, and Withdrawal.

The Annals of pharmacotherapy, 2016

Research

Gabapentin withdrawal syndrome.

Clinical neuropharmacology, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.